Amgen Presents Positive Data From Rituxan Biosimilar Study science science / science 4 years ago 241 Views comments Amgen (AMGN) markets Mvasi and Kanjinti, biosimilar versions of Avastin and Herceptin, respectively in the United States, and Kanjinti and Amgevita, biosimilar of Humira, in the EU. Read more
Comments